SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001457612-22-000051
Filing Date
2022-04-29
Accepted
2022-04-29 16:21:22
Documents
17
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A gnca-20211231.htm   iXBRL 10-K/A 549520
2 EX-10.30 a2021gnca10-kaexx1030.htm EX-10.30 12539
3 EX-31.1 a2021gnca10-kaexx311.htm EX-31.1 5781
4 EX-31.2 a2021gnca10-kaexx312.htm EX-31.2 5424
8 gnca-20211231_g1.jpg GRAPHIC 16581
9 image_2a.jpg GRAPHIC 81
  Complete submission text file 0001457612-22-000051.txt   877985

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT gnca-20211231.xsd EX-101.SCH 1918
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT gnca-20211231_lab.xml EX-101.LAB 36543
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT gnca-20211231_pre.xml EX-101.PRE 19494
11 EXTRACTED XBRL INSTANCE DOCUMENT gnca-20211231_htm.xml XML 17960
Mailing Address 100 ACORN PARK DRIVE CAMBRIDGE MA 02140
Business Address 100 ACORN PARK DRIVE CAMBRIDGE MA 02140 617-876-8191
GENOCEA BIOSCIENCES, INC. (Filer) CIK: 0001457612 (see all company filings)

IRS No.: 510596811 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-36289 | Film No.: 22875871
SIC: 2836 Biological Products, (No Diagnostic Substances)